New test hope for breast cancer treatment

More women with breast cancer could be spared chemotherapy if doctors switched to a new genetic test, according to UK research.

The EndoPredict test can more accurately predict whether a woman's cancer will metastasise than the standard test.

It also can produce results in just a few days compared to around 14 days for the current test, Oncotype DX, which has to be posted to the US.